Drugs Health Pharma

EFSA issues warning on bird flu spread, says humans lack immunity  

HQ Team April 3, 2024: Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian.

Read More
Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

Read More
Drugs Health Pharma

France’s decision to vaccinate ducks against HPAI virus invites US ban

HQ Team October 3, 2023: France has started a vaccination programme for farmed ducks to protect them against highly pathogenic avian influenza (HPAI).

Read More
Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

Read More
Climate Health Pharma

Strasbourg Court begins hearing on climate charges against 33 nations

HQ Team September 27, 2023: Thirty-three governments got dragged to the Strasbourg Court by six Portugal adolescents, who argued the states were acting.

Read More
Drugs Health Pharma

Japan approves Eisai Co, Biogen Inc’s Leqembi for Alzheimer’s 

HQ Team September 25, 2023: Eisai Co., and Biogen Inc., announced that their drug to treat Alzheimer’s disease and cognitive impairment has been.

Read More
Drugs Health Pharma

GSK Plc gets EU approval for HIV prevention drug Apretude

GSK Plc announced that its subsidiary ViiV Healthcare got a green light from the European Commission for the company’s HIV prevention medicine.

Read More
Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.

Read More
Drugs Health Pharma

EMA recommends stopping sale of GSK’s blood cancer drug in EU

The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.

Read More
Drugs Health Pharma

Illicit meth from Afghanistan a growing global threat: UN body

HQ Team September 12, 20232: Methamphetamine trafficking is expanding rapidly from the EU to Eastern Africa, changing illicit drug markets traditionally focused on.

Read More
X